Dr. Michael A. Trauner, MD

Dr. Trauner practices at Golden State Dermatopathology in Walnut Creek, California.

Dr. Trauner's NPI, 1558460394, was assigned on September 21, 2006. Dr. Trauner graduated from Duke University School Of Medicine in 1994. Dr. Trauner's California license number on file is A54693.

Dr. Trauner's primary practice is Golden State Dermatopathology, at 370 N Wiget Ln, Ste 250, Walnut Creek, CA 94598. The practice phone is (925) 278-7592.

Dr. Trauner's primary practice is Golden State Dermatopathology in Walnut Creek, California. The medical group on file is Golden State Dermatology. Dmand AI also links Dr. Trauner to 1 more group practice or clinic, named with a free account. Dr. Trauner's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trauner practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Trauner's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Trauner is board certified in dermatology by the American Board of Dermatology. Dr. Trauner has a license on file in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and hives among the conditions Dr. Trauner treats.

CMS data shows 801 Medicare services from Dr. Trauner across 14 procedure codes in 2024, for 270 Medicare patients. Medicare paid $256,958 for them. Every service was in an office.

CMS counts 270 Medicare patients who saw Dr. Trauner in 2024. The largest group is 75 to 84, with 120 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Trauner's median patient age at 68, with 51% women.

In 2024, Dr. Trauner wrote 61 Medicare Part D claims for 32 patients. 100% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $91 in total drug cost. In 2023, CMS named 78 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Trauner for performance year 2024, reported as part of a group.

Dmand AI links 133 papers to Dr. Trauner, published from 2006 to 2023. 2019 was the busiest year, with 10. The most frequent topics are Liver, Liver Cirrhosis and Bile Acids and Salts. Dr. Trauner has published most often in Hepatology. Dr. Trauner's most frequent co-authors are Christopher L. Bowlus, MD, Patrick Philipp Starlinger and Kris V. Kowdley, MD.

Dmand AI links Dr. Trauner to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Cholangitis, Sclerosing, Cholangitis and Non-alcoholic Fatty Liver Disease. Dr. Falk Pharma GmbH sponsors the most, 2.

CMS Open Payments shows 60 general payments to Dr. Trauner from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Abbvie Inc. paid the most, $293.

Dmand AI lists 3 awards for Dr. Trauner, most recently CMS Stage 1 EHR in 2013.

Dr. Trauner graduated from Duke University School Of Medicine in 1994. Dr. Trauner is a member of AAD and ASDS.

Dr. Trauner is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.